Molina Healthcare (MOH) Stock Forecast & Price Target

$310.30 -1.60 (-0.51%)

(As of 04:40 PM ET)

Molina Healthcare - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 13 Analyst Ratings

Sell
1

Hold
6

Buy
6

Based on 13 Wall Street analysts who have issued ratings for Molina Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 1 has given a sell rating, 6 have given a hold rating, 5 have given a buy rating, and 1 has given a strong buy rating for MOH.

Consensus Price Target

$367.17
18.33% Upside

According to the 13 analysts' twelve-month price targets for Molina Healthcare, the average price target is $367.17. The highest price target for MOH is $439.00, while the lowest price target for MOH is $297.00. The average price target represents a forecasted upside of 18.33% from the current price of $310.30.

Get the Latest News and Ratings for MOH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Molina Healthcare and its competitors.

MOH Analyst Ratings Over Time

Type	Current Forecast 12/5/23 to 12/4/24	1 Month Ago 11/5/23 to 11/4/24	3 Months Ago 9/6/23 to 9/5/24	1 Year Ago 12/5/22 to 12/5/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	6 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$367.17	$367.17	$378.00	$349.82
Forecasted Upside	18.33% Upside	11.04% Upside	14.16% Upside	-4.68% Downside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

Meet the NYSE traded company behind a potentially blockbuster antiviral drug (Ad)

This public company’s one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market Imagine a drug that could treat VIRUSES— such as RSV, COVID-19, Influenza, Bird Flu, Monkey Pox, and more.

The world is changing and so are our viruses. Learn more about the company that could largely benefi

MOH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MOH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Molina Healthcare Stock vs. The Competition

Type	Molina Healthcare	Medical Companies	S&P 500
Consensus Rating Score	2.46	2.80	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	18.25% Upside	26,783.74% Upside	7.75% Upside
News Sentiment Rating	Positive News See Recent MOH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/4/2024	Wells Fargo & Company 3 of 5 stars		Boost Target	Equal Weight ➝ Equal Weight	$360.00 ➝ $362.00	+10.70%
10/25/2024	Barclays 3 of 5 stars		Boost Target	Equal Weight ➝ Equal Weight	$359.00 ➝ $372.00	+12.74%
10/24/2024	Cantor Fitzgerald 3 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$406.00 ➝ $406.00	+22.41%
10/24/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$405.00 ➝ $331.00	+20.48%
7/29/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$354.00 ➝ $353.00	+6.02%
7/25/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Equal Weight ➝ Equal Weight	$320.00 ➝ $320.00	-1.32%
Get the Latest News and Ratings for MOH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Molina Healthcare and its competitors with MarketBeat's FREE daily newsletter.
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$354.00 ➝ $297.00	+2.86%
7/24/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$412.00 ➝ $351.00	+21.57%
7/15/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$440.00 ➝ $400.00	+36.52%
7/10/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$420.00 ➝ $395.00	+38.68%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/28/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underperform	$439.00	+4.90%
12/21/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$350.00 ➝ $380.00	+7.26%
7/14/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$365.00	+21.87%
4/28/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$347.00 ➝ $350.00	+17.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 05:13 PM ET.

Should I Buy Molina Healthcare Stock? MOH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, December 1, 2024. Please send any questions or comments about these Molina Healthcare pros and cons to contact@marketbeat.com.

Molina Healthcare
Bull Case

Here are some ways that investors could benefit from investing in Molina Healthcare, Inc.:

Molina Healthcare, Inc. recently reported earnings of $6.01 per share, exceeding the consensus estimate of $5.96, indicating strong financial performance and effective management.
The company has a solid market capitalization of approximately $17.04 billion, reflecting its significant presence in the healthcare sector and potential for growth.
With a return on equity of 27.88%, Molina Healthcare, Inc. demonstrates efficient use of shareholders' equity to generate profits, which is attractive to investors seeking high returns.
The stock is currently trading at $297.97, showing a recent increase of 2.5%, which may indicate positive market sentiment and potential for further appreciation.
Molina Healthcare, Inc. has a relatively low debt-to-equity ratio of 0.53, suggesting a conservative approach to leveraging, which can reduce financial risk for investors.

Molina Healthcare
Bear Case

Investors should be bearish about investing in Molina Healthcare, Inc. for these reasons:

The stock has experienced significant volatility, with a 52-week high of $423.92 and a low of $272.69, indicating potential risks associated with price fluctuations.
Molina Healthcare, Inc. has a price-to-earnings (P/E) ratio of 15.12, which may suggest that the stock is overvalued compared to its earnings, potentially limiting future price appreciation.
The company's net margin of 2.92% is relatively low, which could indicate challenges in maintaining profitability amidst rising operational costs.
Institutional investors hold 98.50% of the stock, which may lead to less liquidity and increased volatility, as large trades can significantly impact the stock price.
Recent changes in institutional holdings, such as Thrivent Financial reducing its stake by 4.6%, may signal a lack of confidence among major investors, which could affect market perception.

MOH Forecast - Frequently Asked Questions

: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Molina Healthcare is $367.17, with a high forecast of $439.00 and a low forecast of $297.00.
: 13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last year. There is currently 1 sell rating, 6 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MOH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MOH, but not buy additional shares or sell existing shares.
: According to analysts, Molina Healthcare's stock has a predicted upside of 18.33% based on their 12-month stock forecasts.
: Molina Healthcare has been rated by research analysts at Barclays, Cantor Fitzgerald, Robert W. Baird, and Wells Fargo & Company in the past 90 days.
: Analysts like Molina Healthcare less than other "medical" companies. The consensus rating for Molina Healthcare is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MOH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Coins Set to Soar with a Pro-Crypto White House (Ad)

Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over $3 Million worth of crypto – and he's not the only one at the top interested in digital assets…

Click here to reserve your free seat at the Crypto Community Summit

This page (NYSE:MOH) was last updated on 12/4/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Molina Healthcare (MOH) Stock Forecast & Price Target